People with cystic fibrosis are living longer than ever, but those in Canada live nearly 10 years longer than those in the United States, a new study finds.
Regeneron Pharmaceuticals and Sanofi have announced that Health Canada approved Kevzara (sarilumab). Regulatory decisions for Kevzara are anticipated in the US and European Union later this year.